226 related articles for article (PubMed ID: 20838028)
21. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
22. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of oxymatrine on hepatocyte apoptosis
Zhang X; Jiang W; Zhou AL; Zhao M; Jiang DR
World J Gastroenterol; 2017 Jun; 23(21):3839-3849. PubMed ID: 28638224
[TBL] [Abstract][Full Text] [Related]
24. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Cho HI; Park JH; Choi HS; Kwak JH; Lee DU; Lee SK; Lee SM
J Nat Prod; 2014 Nov; 77(11):2497-503. PubMed ID: 25382719
[TBL] [Abstract][Full Text] [Related]
25. Sedum sarmentosum Bunge extract ameliorates lipopolysaccharide- and D-galactosamine-induced acute liver injury by attenuating the hedgehog signaling pathway via regulation of miR-124 expression.
Hao L; Liu MW; Gu ST; Huang X; Deng H; Wang X
BMC Complement Med Ther; 2020 Mar; 20(1):88. PubMed ID: 32178661
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
Huang H; Zhang X; Li J
J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
[TBL] [Abstract][Full Text] [Related]
27. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Chen EQ; Gong DY; Leng XH; Bai L; Liu C; Wang LC; Tang H
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):624-9. PubMed ID: 23232634
[TBL] [Abstract][Full Text] [Related]
29. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
[TBL] [Abstract][Full Text] [Related]
30. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
Takamura M; Matsuda Y; Yamagiwa S; Tamura Y; Honda Y; Suzuki K; Ichida T; Aoyagi Y
Life Sci; 2007 Mar; 80(14):1335-44. PubMed ID: 17300814
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Wu YL; Lian LH; Jiang YZ; Nan JX
J Pharm Pharmacol; 2009 Oct; 61(10):1375-82. PubMed ID: 19814871
[TBL] [Abstract][Full Text] [Related]
32. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
33. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM
Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779
[TBL] [Abstract][Full Text] [Related]
34. Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.
Gong X; Luo FL; Zhang L; Li HZ; Wu MJ; Li XH; Wang B; Hu N; Wang CD; Yang JQ; Wan JY
Int Immunopharmacol; 2010 Mar; 10(3):357-63. PubMed ID: 20036342
[TBL] [Abstract][Full Text] [Related]
35. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
[TBL] [Abstract][Full Text] [Related]
36. Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice.
Xing WW; Zou MJ; Liu S; Xu T; Gao J; Wang JX; Xu DG
Cytokine; 2011 Nov; 56(2):174-9. PubMed ID: 21843953
[TBL] [Abstract][Full Text] [Related]
37. 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling.
Tomar S; Nagarkatti M; Nagarkatti PS
Br J Pharmacol; 2015 Apr; 172(8):2133-47. PubMed ID: 25521277
[TBL] [Abstract][Full Text] [Related]
38. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Kim SJ; Kim JK; Lee DU; Kwak JH; Lee SM
Eur J Pharmacol; 2010 Jun; 635(1-3):188-93. PubMed ID: 20303938
[TBL] [Abstract][Full Text] [Related]
39. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Wu YL; Lian LH; Wan Y; Nan JX
Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
[TBL] [Abstract][Full Text] [Related]
40. The protective effects of total saponins from Ornithogalum saundersiae (Liliaceae) on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Ying-Wan ; Wu YL; Feng XC; Lian LH; Jiang YZ; Nan JX
J Ethnopharmacol; 2010 Nov; 132(2):450-5. PubMed ID: 20713143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
